New York, July 19, 2018: The apheresis market is expected to exceed more than US$ 3.5 billion by 2024 and will grow at a CAGR of more than 11.5% in the given forecast period.
The Apheresis market is segmented on the lines of its product, application, procedure and technology. Based on product segmentation it covers apheresis machine and disposable apheresis kits. Under application segmentation it covers renal diseases, neurology, hematology and others. The apheresis market is segmented on the lines of its procedure like plasmapheresis, leukapheresis, LDL-apheresis, plateletpheresis, erythrocytapheresis, photopheresis and others. Based on technology segmentation it covers membrane filtration and centrifugation. The apheresis market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
The scope of the report includes a detailed study of global and regional markets for Global Apheresis Market with the reasons given for variations in the growth of the industry in certain regions.
Brows Full Report from here: https://www.marketresearchengine.com/reportdetails/apheresis-market-report
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Fresenius Kabi; Haemonetics; Terumo BCT; Therakos, Inc.; Asahi Kasei Kuraray Medical Co Ltd; and B. Braun Melsungen AG. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The restraining factors of Global Apheresis Market are as follows:
- Expensive therapy
• Need of donor availability and histocompatibility
• Risks related with apheresis
• Lack of highly skilled professionals
This report provides:
1) An overview of the Global Apheresis Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Global Apheresis Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The major driving factors of Global Apheresis Market are as follows:
- Increasing number of platelet donors
• Development in the demand for plasma
• Reimbursement policies
The Global Apheresis Market has been segmented as below:
The Global Apheresis Market this market is segmented on the basis of Technology Analysis, Product Segment Analysis, Application Analysis, Procedure Analysis and Regional Analysis.
By Technology Analysis this market is segmented on the basis of Membrane Filtration and Centrifugation. By Product Segment Analysis this market is segmented on the basis of Apheresis machine and Disposable apheresis kits.
By Application Analysis this market is segmented on the basis of Renal diseases, Neurology, Hematology and Others. By Procedure Analysis this market is segmented on the basis of Plasmapheresis, Leukapheresis, LDL-apheresis, Plateletpheresis, Erythrocytapheresis, Photopheresis and Others. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/apheresis-market-report
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Global Apheresis Market, By Procedure
8 Global Apheresis Market, By Product
9 Global Apheresis Market, By Technology
10 Global Apheresis Market, By Application
11 Apheresis Market, By Region
12 Competitive Landscape
13 Company Profiles
13.2 Cerus Corporation
13.3 Fresenius SE & Co. KGaA
13.4 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
13.5 Haemonetics Corporation
13.6 Terumo BCT, Inc.
13.7 Hemacare Corporation
13.8 B. Braun Melsungen AG
13.9 Kaneka Corporation
13.10 Kawasumi Laboratories Inc.
13.11 Nikkiso Co., Ltd.
Contact Person: John Bay
Country: United States